Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000798174 | SCV000937775 | pathogenic | Charcot-Marie-Tooth disease type 4A | 2018-12-13 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine with proline at codon 157 of the GDAP1 protein (p.Thr157Pro). The threonine residue is moderately conserved and there is a small physicochemical difference between threonine and proline. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in an individual affected with Charcot-Marie-Tooth disease (PMID: 15805163), which is consistent with an autosomal dominant pattern of inheritance. ClinVar contains an entry for this variant (Variation ID: 4199). This variant has been reported to affect GDAP1 protein function via a dominant-negative or gain-of-function mechanism (PMID: 19782751, 23628762, 21890626, 18021315, 28220846). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000004419 | SCV000024592 | pathogenic | Charcot-Marie-Tooth disease axonal type 2K | 2005-04-01 | no assertion criteria provided | literature only | |
Gene |
RCV001533514 | SCV001750196 | not provided | Charcot-Marie-Tooth disease | no assertion provided | literature only | ||
Inherited Neuropathy Consortium Ii, |
RCV000798174 | SCV004174628 | uncertain significance | Charcot-Marie-Tooth disease type 4A | 2016-01-06 | no assertion criteria provided | literature only |